Miro Popara A.D. (MIRO)

Market Cap	92.95M
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	631,561
Open	3.380
Previous Close	3.390
Day's Range	3.380 - 3.390
52-Week Range	0.910 - 3.730
Beta	0.02
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About MIRO

Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells. The company has collaborations with The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company was formerly known as TayTech, Inc. Miromatrix Medical Inc. was incorporated...

• Industry: Biotechnology
• Sector: Healthcare
• IPO Date: Jun 24, 2021
• Country: Serbia
• Stock Exchange: NASDAQ
• Ticker Symbol: MIRO

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Dec 15, 2023

Data Sources Report a data error